Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Neurology Today in 5

Neurology Today in 5

Neurology Today in 5

Auteur(s): American Academy of Neurology
Écouter gratuitement

À propos de cet audio

 Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.2024 Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI

    Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI
    Dec 4 2025

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.
    Voir plus Voir moins
    5 min
  • Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

    Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology
    Nov 20 2025

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.
    Voir plus Voir moins
    5 min
  • 50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

    50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia
    Nov 6 2025

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.
    Voir plus Voir moins
    4 min
Tout
Les plus pertinents
Initially I was looking forward to this podcast however, after struggling through the introduction, then the first episode, I will not be continuing. The dr, narrator speaks rapidly, loosing enunciation and clarity and therefore the audience .

disappointing

Un problème est survenu. Veuillez réessayer dans quelques minutes.